Pirfenidone and Nintedanib for Treatment of Idiopathic Pulmonary Fibrosis

Gayathri Sathiyamoorthy, MD; Sameep Sehgal, MD; Rendell W. Ashton, MD

Disclosures

South Med J. 2017;110(6):393-398. 

In This Article

Drug Costs

Pirfenidone costs an average of $95,000/year and nintedanib costs an average of $98,000/year of therapy.[13] Assistance programs are offered by the manufacturers of both drugs, and many insurance plans will cover the medication after authorization, based on appropriate patient selection.

Comments

3090D553-9492-4563-8681-AD288FA52ACE

processing....